Tenax Therapeutics
TNX-103
PH-HFpEF
Countdown
54days
Phase 3 readout Β· Aug 29, 2026
What's at stake
Phase 3 trial results for TNX-103 in PH-HFpEF are due Aug 29, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
Β· SEC 8-K
verified 12h ago
βThe Company now expects to report data in August 2026, and in the weeks ahead will proceed towards the planned database lock and statistical analysis.β